Zusammenfassung
Monozyten und Leukozyten interagieren mit dem Hämostasesystem über verschiedene Mechanismen. Aktivierte Monozyten und Leukozyten können das plasmatische Gerinnungssystem durch die Expression von Tissue Factor aktivieren. Die daraus resultierende Fibrinbildung trägt dazu bei, den Entzündungsprozess zu begrenzen, und behindert die Ausbreitung von Bakterien und anderen Krankheitserregern. Durch direkten zellulären Kontakt können Monozyten und Leukozyten Endothelzellen aktivieren und eine prokoagulatorische Antwort induzieren. Dies wird durch die Sezernierung von Zytokinen und anderen proinflammatorischen Mediatoren verstärkt, die neben der Endothelzellaktivierung die hepatische Synthese von Gerinnungsfaktoren stimulieren können. Weiterhin sind Monozyten und Leukozyten eine Hauptquelle für die Bildung von an Tissue Factor reichen Mikropartikeln. Diese ermöglichen die Aufrechterhaltung einer basalen Gerinnungsaktivierung, sind in die Gerinnselbildung involviert und spielen wahrscheinlich eine wichtige Rolle in der Pathogenese von thromboembolischen Prozessen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bogdanov VY et al. (2003) Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 9(4): 458–462
Guha M, Mackman N (2002) The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277(35): 32124–32132
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16): 1685–1695
Mackman N (2004) Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 24(6): 1015–1022
Muth H et al. (2005) Differential gene expression in activated monocyte derived macrophages following binding of factor VIIa to tissue factor. Thromb Haemost 94(5): 1028–1034
Napoleone E, Di Santo A, Lorenzet R (1997) Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk. Blood 89(2): 541–549
Pawlinski R et al. (2004) Role of tissue factor in haemostasis, thrombosis, angiogenesis and inflammation: lessons from low tissue factor mice. Thromb Haemost 92(3): 444–450
Steffel J, Luscher TF, Tanner FC (2006) Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113(5): 722–731
Szotowski B et al. (2005) Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 96(12): 1233–1239
Wilcox JN et al. (1989) Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86(8): 2839–2843
Mesri M, Altieri DC (1998) Endothelial Cell Activation by Leukocyte Microparticles. J Immunol 161: 4382–4387
Hugel B, Martinez MC, Kunzelmann C et al. (2005) Membrane microparticles: two sides of the coin. Physiology 20: 22–27
Albanese J, Meterissian S, Kontogiannea M et al. (1998) Biologically active Fas antigen and its cognate ligand are expressed on plasma membrane derived extracellular vesicles. Blood 91:3862–3874
MacKenzie A, Wilson HL, Kiss-Toth E et al. (2001) Rapid secretion of interleukin-1-beta by microvesicle shedding. Immunity 15: 825–835
Fourcade O, Simon MF, Viode C et al. (1995) Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80: 919–927
Hess C, Sadallah S, Hefti A et al. (1999) Ectosomes released by human neutrophils are specialized functional units. J Immunol 163: 4564–4573
Boulanger CM, Scoazec A, Ebrahimian T et al. (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104: 2649–2652
Martin S, Tesse A, Hugel B et al. (2004) Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation 109: 1653–1659
Leroyer AS, Isobe H, Leseche G et al. (2007) Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 49: 772–777
Mesri M, Altieri DC (1999) Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem 274: 23111–23118
Osterud B (2001) The role of platelets in decrypting monocyte tissue factor. Semin Hematol 38: 2–5
Giesen PLA, Rauch U, Bohrmann B et al. (1999) Blood-borne tissue factor: Another view of thrombosis. Prc Nat Acad Sci USA 96: 2311–2315
Eilertsen KE, Osterud B (2004) Tissue factor: (patho)physiology and cellular biology. Blood Coagul Fibrinolysis 15: 521–538
Afshar-Kharghan V, Thiagarajan P (2006) Leukocyte adhesion and thrombosis. Curr Opin Hematol 13: 34–39
Charo IF, Taubman MB (2004) Chemokines in the pathogenesis of vascular disease. Circ Res 95: 858–866
Schecter AD, Rollins BJ, Zhang YJ et al. (1997) Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem 272: 28568–28573
Nourshargh S, Krombach F, Dejana E (2006) The role of JAM-A and PECAM-1 in modulating leukocyte infiltration in inflamed and ischemic tissues. J Leukoc Biol 80: 714–718
Ostermann G, Weber KS, Zernecke A et al. (2002) JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 3: 151–158
Mause SF, von Hundelshausen P, Zernecke A (2005) Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 25: 1512–1518
Suk K, Cha S (1999) Thrombin-induced interleukin-8 production and its regulation by interferon-gamma and prostaglandin E2 in human monocytic U937 cells. Immunol Lett 67: 223–227
McEver RP, Cummings RD (1997) Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 100: 485–491
Merten M, Beythien C, Gutensohn K et al. (2005) Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation. Arterioscler Thromb Vasc Biol 25: 258–263
Vandendries ER, Furie BC, Furie B (2004) Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 92: 459–466
Merten M, Thiagarajan P (2000) P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 102: 1931–1936
Palabrica T, Lobb R, Furie BC et al. (1992) Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359: 848–851
Subramaniam M, Frenette PS, Saffaripour S et al. (1996) Defects in hemostasis in P-selectin-deficient mice. Blood 87: 1238–1242
Plescia J, Altieri DC (1996) Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J 319 (Pt3): 873–879
Trumel C, Si-Tahar M, Balloy V et al. (2000) Phosphoinositide 3-kinase inhibition reverses platelet aggregation triggered by the combination of the neutrophil proteinases elastase and cathepsin G without impairing alpha(IIb)beta(3) integrin activation. FEBS Lett 484: 184–188
Vischer UM, Jornot L, Wollheim CB et al. (1995) Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells. Blood 85: 3164–3172
Weber C, Schober A, Zernecke A (2004) Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol 24(11): 1997–2008
Linton MF, Fazio S (2003) Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 27(Suppl 3): S35–S40
Schober A, Weber C (2005) Mechanisms of monocyte recruitment in vascular repair after injury. Antioxid Redox Signal 7(9–10): 1249–1257
von Hundelshausen P, Weber C (2007) Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 100(1): 27–40
Bernhagen J et al. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13(5): 587–596
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16): 1685–1695
Lusis AJ (2000) Atherosclerosis. Nature 407(6801): 233–241
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Weber, C. (2010). Monozyten und Leukozyten. In: Pötzsch, B., Madlener, K. (eds) Hämostaseologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01544-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-01544-1_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01543-4
Online ISBN: 978-3-642-01544-1
eBook Packages: Medicine (German Language)